Ajay Sheshadri MD MSCI
Asthma & COPD, Infectious Disease, Pleural Disease, Thoracic Oncology
Associate Professor of Pulmonary Medicine
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-563-1987
Dr. Sheshadri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2007 - 2010
University of Texas Southwestern Medical SchoolClass of 2007
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
TN State Medical License 2023 - 2028
GA State Medical License 2023 - 2027
LA State Medical License 2023 - 2027
TX State Medical License 2009 - 2027
AL State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- Join now to see all
Clinical Trials
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
- Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome Start of enrollment: 2020 Aug 27
- Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer Start of enrollment: 2021 Jan 21
Publications & Presentations
PubMed
- Refractory immune-related adverse events (irAEs) associated with immune checkpoint inhibitor therapy: a multiorgan management review.Maria Julia Moura, Anirudha Chatterjee, Sharada Wali, Devin R Garza, Hamza Salim
Expert Opinion on Drug Safety. 2026-04-19 - 1 citationsMacrophage CCL18 promotes lung inflammation in checkpoint inhibitor pneumonitis.Mohammad I Ghanbar, Andres Villabona-Rueda, Nicolas Philip, Romy Rodriguez Ortega, Shannon Fonti
American Journal of Respiratory Cell and Molecular Biology. 2026-04-01 - Pulmonary Complications of Cancer Therapy: Clinical Presentations, Imaging Patterns, and Management Strategies.Bilal Zafar, Tasmea Haque, Miranda Tan, Ritika Singh, Lara Bashoura
Medicina. 2026-03-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
